CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,000 | -76.9% | 766 | -76.0% | 0.00% | -66.7% |
| Q4 2019 | $52,000 | +940.0% | 3,195 | +805.1% | 0.00% | – |
| Q3 2019 | $5,000 | -16.7% | 353 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -89.5% | 353 | -89.1% | 0.00% | -100.0% |
| Q1 2019 | $57,000 | -6.6% | 3,229 | -6.3% | 0.01% | 0.0% |
| Q4 2018 | $61,000 | +1425.0% | 3,446 | +1235.7% | 0.01% | – |
| Q3 2018 | $4,000 | +300.0% | 258 | +386.8% | 0.00% | – |
| Q1 2018 | $1,000 | -83.3% | 53 | -90.3% | 0.00% | -100.0% |
| Q4 2017 | $6,000 | +20.0% | 549 | +13.7% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 483 | -11.4% | 0.00% | – |
| Q2 2017 | $5,000 | -28.6% | 545 | -12.0% | 0.00% | -100.0% |
| Q1 2017 | $7,000 | +40.0% | 619 | +74.9% | 0.00% | – |
| Q4 2016 | $5,000 | – | 354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|